X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (783) 783
humans (539) 539
arylsulfotransferase - metabolism (389) 389
animals (356) 356
male (303) 303
arylsulfotransferase - genetics (291) 291
female (257) 257
arylsulfotransferase (211) 211
pharmacology & pharmacy (207) 207
rats (205) 205
kinetics (184) 184
biochemistry & molecular biology (168) 168
liver - enzymology (167) 167
sulfotransferase (145) 145
middle aged (135) 135
sulfotransferases - metabolism (134) 134
adult (130) 130
substrate specificity (129) 129
sulfation (129) 129
toxicology (126) 126
metabolism (111) 111
enzymes (109) 109
phenol sulfotransferase (106) 106
aged (101) 101
genotype (100) 100
sulfotransferases - genetics (93) 93
oncology (92) 92
sulfates - metabolism (89) 89
expression (88) 88
liver (87) 87
molecular sequence data (79) 79
sult1a1 (78) 78
arylsulfotransferase - chemistry (77) 77
arylsulfotransferase - antagonists & inhibitors (73) 73
sulfurtransferases - metabolism (70) 70
polymorphism, genetic (69) 69
liver - metabolism (68) 68
mice (68) 68
amino acid sequence (65) 65
cytosol - enzymology (65) 65
isoenzymes - metabolism (65) 65
risk factors (61) 61
blood platelets - enzymology (60) 60
liver - drug effects (59) 59
analysis (57) 57
cancer (57) 57
pharmacogenetics (57) 57
phenolsulfotransferase (57) 57
purification (57) 57
case-control studies (56) 56
base sequence (54) 54
estrogen sulfotransferase (54) 54
recombinant proteins - metabolism (53) 53
association (52) 52
phosphoadenosine phosphosulfate - metabolism (52) 52
sulfates (51) 51
molecular-cloning (50) 50
biotransformation (49) 49
human cytosolic sulfotransferases (49) 49
hydrogen-ion concentration (49) 49
rat-liver (49) 49
glucuronosyltransferase - metabolism (48) 48
aryl sulfotransferase (47) 47
dopamine - metabolism (46) 46
polymorphism (46) 46
rats, inbred strains (46) 46
genetic predisposition to disease (45) 45
genetics & heredity (45) 45
polymerase chain reaction (45) 45
in vitro techniques (44) 44
physiological aspects (44) 44
arylsulfotransferase - isolation & purification (42) 42
breast cancer (42) 42
cells, cultured (42) 42
genes (42) 42
genetic aspects (42) 42
genetic polymorphisms (42) 42
partial-purification (42) 42
rats, sprague-dawley (42) 42
human liver (41) 41
gene expression (40) 40
phenols (40) 40
phenols - metabolism (40) 40
research (40) 40
aged, 80 and over (39) 39
chromatography, high pressure liquid (39) 39
cloning, molecular (39) 39
metabolites (39) 39
breast neoplasms - genetics (38) 38
cell line (38) 38
inhibition (38) 38
activation (37) 37
sulfotransferases (37) 37
enzyme inhibitors - pharmacology (36) 36
dopamine (35) 35
dose-response relationship, drug (35) 35
polymorphism, single nucleotide (35) 35
article (34) 34
binding sites (34) 34
isoenzymes - genetics (34) 34
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 07/2011, Volume 89, Issue 1-2, pp. 57 - 64
Journal Article
Chemico-Biological Interactions, ISSN 0009-2797, 06/2015, Volume 234, pp. 309 - 319
Estrogens have important roles in the pathogenesis of endometrial cancer. They can have carcinogenic effects through stimulation of cell proliferation or... 
Aromatase pathway | Sulfatase pathway | Phase I and phase II estrogen metabolism | Aldo–keto reductase 1C3 (AKR1C3) | 17β-Hydroxysteroid dehydrogenases (17β-HSDs, HSD17B) | Catechol-O-methyl transferase (COMT) | 17b-Hydroxysteroid dehydrogenases | (17b-HSDs HSD17B)Aldoketo reductase 1C3 (AKR1C3) | 17 beta-Hydroxysteroid dehydrogenases (17 beta-HSDs, HSD17B) | DEHYDROGENASES | QUINONES | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROGESTERONE ACTION | 17-BETA-ESTRADIOL | CARCINOGENESIS | OVARIAN ENDOMETRIOSIS | Aldo-keto reductase 1C3 (AKR1C3) | ENZYMES | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PHASE-I | CARCINOMA | PRE-RECEPTOR REGULATION | Sulfatases - genetics | Progesterone Reductase - metabolism | Humans | Endometrial Neoplasms - metabolism | Aromatase - metabolism | Catechol O-Methyltransferase - genetics | Hydroxyprostaglandin Dehydrogenases - metabolism | Androstenedione - metabolism | Catechol O-Methyltransferase - metabolism | Aromatase - genetics | Endometrial Neoplasms - genetics | Sulfatases - metabolism | Estrogens - genetics | 3-Hydroxysteroid Dehydrogenases - metabolism | Female | Sulfotransferases - metabolism | Estrogens - metabolism | Quinones - pharmacology | Glutathione S-Transferase pi - genetics | Sulfotransferases - genetics | Estrone - genetics | Quinone Reductases - metabolism | Androstenedione - genetics | Glutathione S-Transferase pi - metabolism | Estrogens - biosynthesis | RNA, Messenger - genetics | Transcriptome - genetics | Progesterone Reductase - genetics | Arylsulfotransferase - genetics | Hydroxyprostaglandin Dehydrogenases - genetics | Estrone - analogs & derivatives | Aldo-Keto Reductase Family 1 Member C3 | Estrone - metabolism | Cell Line, Tumor | Quinone Reductases - genetics | 3-Hydroxysteroid Dehydrogenases - genetics | Arylsulfotransferase - metabolism | Physiological aspects | Endometrial cancer | Sulfates | Genes | Estrogen | Steroids | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2005, Volume 97, Issue 1, pp. 30 - 39
Background: The efficacy of tamoxifen therapy for the treatment of breast cancer varies widely among individuals. Plasma concentrations of the active tamoxifen... 
PERFORMANCE LIQUID-CHROMATOGRAPHY | TRIAL | IN-VITRO | PLASMA | ONCOLOGY | JAPANESE POPULATION | ALLELE FREQUENCY | PAROXETINE | POSTMENOPAUSAL WOMEN | HOT FLASHES | CYTOCHROME-P450 2D6 | Cytochrome P-450 CYP2C9 | Cytochrome P-450 CYP2D6 Inhibitors | Prospective Studies | Cytochrome P-450 CYP3A | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Antidepressive Agents, Second-Generation - administration & dosage | Tamoxifen - administration & dosage | Antineoplastic Agents, Hormonal - metabolism | Breast Neoplasms - metabolism | Breast Neoplasms - enzymology | Cyclohexanols - metabolism | Time Factors | Adult | Female | Chemotherapy, Adjuvant | Serotonin Uptake Inhibitors - metabolism | Tamoxifen - metabolism | Cytochrome P-450 CYP2D6 - genetics | Drug Administration Schedule | Enzyme Inhibitors - metabolism | Estrogen Receptor Modulators - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Tamoxifen - blood | Genotype | Arylsulfotransferase - genetics | Estrogen Receptor Modulators - blood | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - blood | Venlafaxine Hydrochloride | Serotonin Uptake Inhibitors - administration & dosage | Cytochrome P-450 Enzyme System - genetics | Aged | Estrogen Receptor Modulators - metabolism | Antidepressive Agents, Second-Generation - metabolism | Breast cancer | Dosage and administration | Drug therapy | Tamoxifen | Antidepressants | Side effects | Metabolism | Index Medicus
Journal Article
Journal Article
Human Reproduction, ISSN 0268-1161, 07/2017, Volume 32, Issue 7, pp. 1465 - 1473
Abstract STUDY QUESTION Are bisphenol A (BPA) and BPA analogs (BPA-A) safe for male human reproductive function? SUMMARY ANSWER The endocrine function of human... 
anti-androgenic compounds | bisphenols | insulin-like factor 3 | testosterone | Leydig cells | endocrine disruptor | human testis | inhibin B | Sertoli cells | reproductive function | SPERM DNA-DAMAGE | UNITED-STATES | SERUM TESTOSTERONE CONCENTRATION | MASS-SPECTROMETRY METHOD | DIGLYCIDYL ETHER BADGE | SEMEN QUALITY | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | HUMAN EXPOSURE | HORMONE CONCENTRATIONS | WIDESPREAD OCCURRENCE | HUMAN URINE | Gene Expression Regulation, Enzymologic - drug effects | Leydig Cells - cytology | Testis - metabolism | Apoptosis - drug effects | Benzhydryl Compounds - toxicity | Phenols - toxicity | Humans | Glucuronidase - metabolism | Male | Leydig Cells - drug effects | Testis - secretion | Nonsteroidal Anti-Androgens - chemistry | Benzhydryl Compounds - chemistry | Sertoli Cells - drug effects | Testis - drug effects | Glucuronosyltransferase - genetics | Testosterone - metabolism | Leydig Cells - metabolism | Sertoli Cells - cytology | Adult | Steryl-Sulfatase - metabolism | Sertoli Cells - metabolism | Steryl-Sulfatase - genetics | Nonsteroidal Anti-Androgens - toxicity | Reproducibility of Results | Sertoli Cells - secretion | Testosterone - secretion | Insulin - agonists | Sulfones - toxicity | Testis - cytology | Endocrine Disruptors - chemistry | Tissue Culture Techniques | Arylsulfotransferase - genetics | Epoxy Compounds - toxicity | Endocrine Disruptors - toxicity | Leydig Cells - secretion | Insulin - metabolism | Proteins - agonists | Proteins - metabolism | Glucuronidase - genetics | Glucuronosyltransferase - metabolism | Testosterone - antagonists & inhibitors | Phenols - chemistry | Arylsulfotransferase - metabolism | Proteins - antagonists & inhibitors | Index Medicus | Life Sciences | Santé publique et épidémiologie
Journal Article
Journal Article
Journal Article
Journal Article
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 09/2017, Volume 172, pp. 46 - 54
Celecoxib is known to alter the preferred position of SULT2A1-catalyzed sulfonation of 17β-estradiol (17β-E2) and other estrogens from the 3- to the... 
Sulfotransferases | Estrogen | Quercetin | Celecoxib | Triclosan | Steroids | Cancer | CONJUGATED EQUINE ESTROGENS | HUMAN-BREAST-CANCER | MCF-7 | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREVENTION | HORMONAL BASIS | HUMAN CYTOSOLIC SULFOTRANSFERASES | INHIBITION | METABOLISM | ENDOCRINOLOGY & METABOLISM | POSTMENOPAUSAL WOMEN | MAMMARY EPITHELIAL-CELLS | Liver - enzymology | Species Specificity | Humans | Male | Isoenzymes - chemistry | Triclosan - pharmacology | Celecoxib - chemistry | Nitrophenols - chemistry | Hepatocytes - cytology | Liver - drug effects | Nitrophenols - pharmacology | Isoenzymes - metabolism | Sulfates - chemistry | Adult | Female | Sulfotransferases - metabolism | Estradiol - pharmacology | Hepatocytes - drug effects | Recombinant Proteins - metabolism | Sulfotransferases - genetics | Estradiol - metabolism | Estrone - pharmacology | Gene Expression | Quercetin - chemistry | Sulfates - metabolism | Isoenzymes - genetics | Arylsulfotransferase - chemistry | Models, Molecular | Rats | Recombinant Proteins - chemistry | Recombinant Proteins - genetics | Celecoxib - pharmacology | Arylsulfotransferase - genetics | Rats, Sprague-Dawley | Triclosan - chemistry | Animals | Quercetin - pharmacology | Estrone - metabolism | Liver - cytology | Molecular Docking Simulation | Structural Homology, Protein | Primary Cell Culture | Arylsulfotransferase - metabolism | Sulfotransferases - chemistry | Hepatocytes - enzymology | COX-2 inhibitors | Dehydroepiandrosterone | Liver | Phenols | Tryptophan | Angiogenesis inhibitors | Sulfates | Estradiol | Estrogens | Estrone sulfotransferase | 17β-Estradiol | p-Nitrophenol | Breast cancer | Glycine | Cytosol | Studies | Steroid sulfatase | Rodents | Sulfonation | Estrone | Sulfate | Steroid hormones | Index Medicus
Journal Article
Journal of Nutrition, ISSN 0022-3166, 2015, Volume 145, Issue 3, pp. 442 - 451
Journal Article